首页> 外文期刊>Nature >Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity
【24h】

Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity

机译:第2组先天性淋巴样细胞促进白色脂肪组织的形成并限制肥胖

获取原文
获取原文并翻译 | 示例
       

摘要

免疫系统现在被认为与遗传因素和环境因素一起涉及到肥胖的形成中。最新研究发现,脂肪组织中的"2-组先天淋巴样细胞"(ILC2S)是造成小鼠发生肥胖的一个因素。David Artis及同事在这项研究中显示,ILC2s通过响应于白介素-33生成"蛋氨酸-脑啡肽"肽在能量平衡中扮演一个关键角色。这会促进米黄色脂肪细胞(从白色脂肪组织出现的一个专门化的脂肪细胞群)的出现。这一"米黄色化"过程导致能量消耗增加和脂肪堆积减少。%Obesity is an increasingly prevalent disease regulated by genetic and environmental factors. Emerging studies indicate that immune cells, including monocytes, granulocytes and lymphocytes, regulate metabolic homeostasis and are dysregulated in obesity. Group 2 innate lymphoid cells (ILC2s) can regulate adaptive immunity and eosinophil and alternatively activated macrophage responses, and were recently identified in murine white adipose tissue (WAT) where they may act to limit the development of obesity. However, ILC2s have not been identified in human adipose tissue, and the mechanisms by which ILC2s regulate metabolic homeostasis remain unknown. Here we identify ILC2s in human WAT and demonstrate that decreased ILC2 responses in WAT are a conserved characteristic of obesity in humans and mice. Interleukin (IL)-33 was found to be critical for the maintenance of ILC2s in WAT and in limiting adiposity in mice by increasing caloric expenditure. This was associated with recruitment of uncoupling protein 1 (UCP1)~+ beige adipocytes in WAT, a process known as beiging or browning that regulates caloric expenditure. IL-33-induced beiging was dependent on ILC2s, and IL-33 treatment or transfer of IL-33-elicited ILC2s was sufficient to drive beiging independently of the adaptive immune system, eosinophils or IL-4 receptor signalling. We found that ILC2s produce methionine-enkephalin peptides that can act directly on adipocytes to upregulate Ucp1 expression in vitro and that promote beiging in vivo. Collectively, these studies indicate that, in addition to responding to infection or tissue damage, ILC2s can regulate adipose function and metabolic homeostasis in part via production of enkephalin peptides that elicit beiging.
机译:免疫系统现在被认为与遗传因素和环境因素一起涉及到肥胖的形成中。最新研究发现,脂肪组织中的"2-组先天淋巴样细胞"(ILC2S)是造成小鼠发生肥胖的一个因素。David Artis及同事在这项研究中显示,ILC2s通过响应于白介素-33生成"蛋氨酸-脑啡肽"肽在能量平衡中扮演一个关键角色。这会促进米黄色脂肪细胞(从白色脂肪组织出现的一个专门化的脂肪细胞群)的出现。这一"米黄色化"过程导致能量消耗增加和脂肪堆积减少。%Obesity is an increasingly prevalent disease regulated by genetic and environmental factors. Emerging studies indicate that immune cells, including monocytes, granulocytes and lymphocytes, regulate metabolic homeostasis and are dysregulated in obesity. Group 2 innate lymphoid cells (ILC2s) can regulate adaptive immunity and eosinophil and alternatively activated macrophage responses, and were recently identified in murine white adipose tissue (WAT) where they may act to limit the development of obesity. However, ILC2s have not been identified in human adipose tissue, and the mechanisms by which ILC2s regulate metabolic homeostasis remain unknown. Here we identify ILC2s in human WAT and demonstrate that decreased ILC2 responses in WAT are a conserved characteristic of obesity in humans and mice. Interleukin (IL)-33 was found to be critical for the maintenance of ILC2s in WAT and in limiting adiposity in mice by increasing caloric expenditure. This was associated with recruitment of uncoupling protein 1 (UCP1)~+ beige adipocytes in WAT, a process known as beiging or browning that regulates caloric expenditure. IL-33-induced beiging was dependent on ILC2s, and IL-33 treatment or transfer of IL-33-elicited ILC2s was sufficient to drive beiging independently of the adaptive immune system, eosinophils or IL-4 receptor signalling. We found that ILC2s produce methionine-enkephalin peptides that can act directly on adipocytes to upregulate Ucp1 expression in vitro and that promote beiging in vivo. Collectively, these studies indicate that, in addition to responding to infection or tissue damage, ILC2s can regulate adipose function and metabolic homeostasis in part via production of enkephalin peptides that elicit beiging.

著录项

  • 来源
    《Nature》 |2015年第7542期|242-246a2|共6页
  • 作者单位

    Jill Roberts Institute for Research in IBD, Joan and Sanford I.Weill Department of Medicine, Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, New York 10021, USA,Department of Microbiology and Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA;

    Department of Microbiology and Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA,Division of Dermatology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA;

    Department of Microbiology and Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA,Immunology Research, Biogen Idec, Inc., Cambridge, Massachusetts 02142, USA;

    Institute for Diabetes, Obesity and Metabolism, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA;

    Jill Roberts Institute for Research in IBD, Joan and Sanford I.Weill Department of Medicine, Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, New York 10021, USA,Department of Microbiology and Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA;

    Jill Roberts Institute for Research in IBD, Joan and Sanford I.Weill Department of Medicine, Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, New York 10021, USA;

    Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York 10032, USA,Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York 10032, USA;

    Columbia Center for Translational Immunology, Columbia University Medical Center, New York, New York 10032, USA,Department of Microbiology and Immunology, Columbia University Medical Center, New York, New York 10032, USA,Department of Surgery, Columbia University Medical Center, New York, New York 10032, USA;

    Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, Pomona, California 91766, USA;

    Institute for Diabetes, Obesity and Metabolism, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA;

    Jill Roberts Institute for Research in IBD, Joan and Sanford I.Weill Department of Medicine, Department of Microbiology and Immunology, Weill Cornell Medical College, Cornell University, New York, New York 10021, USA,Department of Microbiology and Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:52:30

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号